CXCL10: Most consistent cGVHD biomarker?

Blood

Volumn 127, Issue 24, 2016, Pages 2950-2951

  Paczesny, Sophie ^a   Zaid, Mohammad Abu ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; BIOLOGICAL MARKER;

CHRONIC GRAFT VERSUS HOST DISEASE; DIAGNOSTIC VALUE; GENE EXPRESSION; HUMAN; MONOCYTE; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; CHRONIC DISEASE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION;

BIOMARKERS; CHRONIC DISEASE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 84976311659     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-04-709543     Document Type: Review

References (10)

1. + NK cells. Blood. 2016;127(24): 3082-3091.
2. Groom JR, Luster AD. CXCR3 in T cell function. Exp Cell Res. 2011;317(5):620-631.
3. Duffner U, Lu B, Hildebrandt GC, et al. Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol. 2003;31(10):897-902.
4. Paczesny S, Hakim FT, Pidala J, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report. Biol Blood Marrow Transplant. 2015;21(5):780-792.
5. + T cells plays a major role in the pathogenesis of chronic GVHD. Blood. 2012;120(20):4246-4255.
6. Kitko CL, Levine JE, Storer BE, et al. Plasma CXCL9 elevations correlate with chronic GVHD diagnosis. Blood. 2014;123(5):786-793.
7. Ahmed SS, Wang XN, Norden J, et al. Identification and validation of biomarkers associated with acute and chronic graft versus host disease. Bone Marrow Transplant. 2015;50(12):1563-1571.
8. Hakim FT, Memon S, Jin P, et al. Upregulation of interferon-inducible and damage response receptors in chronic graft-versus-host disease [abstract]. Blood. 2015; 126(23). Abstract 922.
9. Sarantopoulos S, Stevenson KE, Kim HT, et al. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clin Cancer Res. 2007; 13(20):6107-6114.
10. Hildebrandt GC, Corrion LA, Olkiewicz KM, et al. Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. J Immunol. 2004;173(3):2050-2059.